|
|
||||||||


* Research Institute for the Biology of Farm Animals (FBN), D-18196 Dummerstorf, Germany
University of Montreal, St-Hyacinthe, Québec, Canada, J2S 7C6
Agriculture and Agri-Food Canada, Station Lennoxville, Sherbrooke, Québec, Canada, J1M 1Z3
1 Corresponding author: hammon{at}fbn-dummerstorf.de
| ABSTRACT |
|---|
|
|
|---|
Key Words: rumen-protected fat glucose metabolism dairy cow portal flux
| INTRODUCTION |
|---|
|
|
|---|
Adequate supply of glucose to the mammary gland is essential to sustain milk production in high-yielding dairy cows (Rigout et al., 2002; Brockman, 2005). However, feeding RPF slightly enhanced milk and lactose yields despite a reduction in plasma glucose concentration (Grummer and Carroll, 1991; van Knegsel et al., 2005; Voigt et al., 2005). Supply and mammary uptake of long-chain fatty acids (LCFA) that are directly incorporated into milk fat combined with a reduction of de novo mammary fat synthesis could spare glucose from oxidative metabolism and partition it toward lactose synthesis (Grummer and Carroll, 1991; Chilliard, 1993; Voigt et al., 2005). However, this is speculative, because little is known on the effect of feeding RPF on glucose metabolism in dairy cows.
In ruminants, glucose mainly originates from gluconeogenesis (85% from the liver and the remainder from the kidney and gut) with very limited net portal absorption (Brockman, 2005). Therefore substituting an energy source such as starch by an isoenergetic amount of RPF could negatively impact glucose supply to the lactating cow. This could potentially occur through a reduction in net portal absorption of glucose precursor originating from rumen carbohydrate fermentation, such as propionate, and a modest decrease in glucose absorption originating from starch escaping rumen digestion (Huntington, 1997; van Knegsel et al., 2005). In the present study, we have therefore investigated an isoenergetic substitution of cornstarch by RPF in a dairy ration on rate of appearance of glucose (RaGluc), net portal flux of nutrients, as well as on metabolic and endocrine parameters relating to glucose metabolism.
| MATERIALS AND METHODS |
|---|
|
|
|---|
After recovery, cows were fed a diet containing cornstarch, but no RPF (SD) for 3 wk, followed by a diet containing RPF (FD) for an additional 3-wk period (Table 1
; Figure 1
). The 2 diets were formulated based on the recommendations of the German Society of Nutrition Physiology (2001) for lactating cows and were calculated to be isonitrogenous and isoenergetic: they differed in their energy sources, primarily by substituting cornstarch in the SD ration with RPF in the FD ration. To supply a similar amount of utilizable proteins with the 2 diets, rumen-protected soybeans substituted soybean meal in the FD treatment, because removing rapidly fermentable starch from the ration would theoretically decrease microbial protein (Table 1
). Diets were fed ad libitum as TMR during the first week of the experimental periods, and refusals were weighed every day to determine feed intake. From the second week of each experimental period onward, cows were fed at 97% of their respective ad libitum intake in 12 equal meals at 2-h intervals during the day and in double portions every 4 h during the night (2000 to 0600 h) to minimize postprandial variations of nutrient absorption. Cows had free access to water and were milked twice daily, at 0500 and 1700 h. Milk production was recorded each day, and milk samples were taken weekly (Wednesday) at morning milkings.
|
|
Milk protein, fat, and lactose concentrations were measured by the infrared spectrophotometric method (Milkoscan, Foss Germany, Rellingen, Germany) according to the MGVO (Milch-Güteverordung milk quality by-law, Germany) at the local dairy-control association (LKV Mecklenburg-Vorpommern, Güstrow, Germany). Energy-corrected milk was calculated according to Reist et al. (2003).
Infusions, Blood Sampling, and Analyses
To determine the rate of appearance of CO2 (RaCO2) as an indirect measure of energy expenditure, cows received an i.v. bolus of NaH13CO3 (2.5 µmol/kg of BW, 99 atom % 13C; Chemotrade Ltd., Leipzig, Germany) on d 16 or 17 of each feeding period (Figure 1
). The NaH13CO3 was dissolved in 0.9% saline and filtered through a 0.2-µm filter before i.v. administration. Blood samples from the jugular vein were taken 10 min before and at 2, 5, 10, 20, 30, 60, 120, 240, and 360 min after NaH13CO3 bolus injection. To determine the 13C enrichment in blood CO2 (representing all acid-volatile CO2 and being a proximate measure for breath 13CO2 enrichment; Junghans et al., 2007), 0.5 mL of heparinized whole blood in a 10-mL glass tube (Exetainer, Labco Ltd., Buckinghamshire, United Kingdom) was treated with 1 mL of lactic acid (10% wt/wt) and sealed airtight by a screwed cap with a rubber septum for 2 h at room temperature. After this time period, the isotopic ratio of the released CO2 was measured in the head-space by gas isotope ratio mass spectrometry (DELTA Plus XL, Thermo Quest, Bremen, Germany) coupled with the Gas Bench II (Finnigan, Bremen, Germany). Enrichments are expressed as atom percent excess (APE). The APE was calculated by difference between the enrichments of each blood sample and the preinfusion baseline abundance.
Glucose oxidation (GOx) and RaGluc were determined on d 18 or 19 of each feeding period (Figures 1
and 2
). A primed (5.4 µmol/kg of BW) continuous D-[U-13C6]glucose infusion (6.3 µmol/kg of BW per h; 99 atom% 13C; Chemotrade Ltd.) was conducted for 4.5 h into a jugular vein. The D-[U-13C6]glucose was dissolved in 0.9% saline and filtered through a 0.2-µm filter before administration. Arterial blood samples were taken 10 min before and 10, 40, 70, 100, 130, 160, 190, and 220 min after the initiation of the D-[U-13C6]glucose infusion. For the determination of the 13C enrichment in blood CO2, 0.5 mL of whole blood was treated as outlined for the bicarbonate infusion. Isotopic enrichments of plasma glucose were measured in heparinized plasma that was harvested and frozen for subsequent analyses. Glucose was converted into the aldonitrile pentaacetate derivative by a modified method of Pfaffenberger et al. (1975). Briefly, acetonitrile (300 µL) was added to a plasma sample (50 µL), and samples were centrifuged at 18,500 x g for 20 min. The supernatant was dried under N2 gas at 60°C, and 100 µL of hydroxylamine hydrochloride solution was added to the vial. The sample was then vortexed and kept at 90°C for 60 min. Acetic anhydride (100 µL) and pyridine (50 µL) were added, and heating was continued at 90°C for another 60 min. Thereafter, samples were dried under N2 at 60°C, and isooctane (100 µL) was added. Samples were then transferred to capped vials and injected into a GC-MS system. Chemicals used were of analytical grade and were purchased from several suppliers (Sigma-Aldrich Chemie GmbH, Steinheim, Germany; Fluka Chemie AG, Buchs, Switzerland).
|
On d 18 or 19 of each feeding period, additional blood samples from the portal vein and the artery were taken simultaneously and transferred into tubes containing EDTA at 30-min intervals for 2.5 h, beginning 70 min after the onset of D-[U-13C6]glucose infusion, to measure glucose, lactate, NEFA, BHBA, triglycerides, acetate, propionate, n-butyrate, free AA, insulin, and glucagon concentrations to calculate net flux across the portal-drained viscera (PDV; Figure 1
). The tubes were immediately put on ice, centrifuged (20 min, 1,500 x g at 4°C), and aliquots were stored at –20°C (–80°C for free AA) until analyzed. Para-aminohippurate (pAH) was infused at a dose of 14.4 g/h (10%: wt/vol) into a mesenteric vein to determine portal plasma flow, starting at least 90 min before the first sampling time.
Plasma concentrations of glucose, lactate, and triglycerides were measured using kits from Labor und Technik Lehmann, Berlin, Germany (GL 0103, LC 0013, and GL TR 0015, respectively) analogous to Reist et al. (2003). Plasma concentrations of NEFA and BHBA were measured using kits from Randox, Krefeld, Germany (FA 115 and RA-RB 1007) analogous to Reist et al. (2003). Analyses were performed at the Landesan-stalt für Landwirtschaft, Rostock, Germany, using the automatic analyzer Cobas Mira Plus (Roche, Basle, Switzerland). Volatile fatty acids were analyzed using GC with flame-ionization detection as previously described (Thivierge et al., 1998). Plasma pAH concentrations were measured with an automatic analyzer (Technicon Autoanalyser II, Technicon Instruments Corporation, Tarrytown, NY; Huntington, 1984).
Insulin was measured by RIA using a porcine kit (PI-12K, Linco Research, St. Charles, MO; Bellmann et al., 2004). Cross-reactivity with bovine insulin was 90%. Intra- and interassay CV were 4.3 and 8.2%, respectively. Glucagon was measured by RIA using a kit from Linco (GL-32K, Linco Research; Hammon and Blum, 1998). Intra- and interassay CV were 7.8 and 13.6%, respectively. The assay is specific for the determination of pancreatic glucagon in plasma in most mammals. Cross-reactivity to oxyntomodulin, which is the primary gut glucagon, is less than 0.1%.
Plasma AA concentrations were measured by isotope dilution using GC-MS (Calder et al., 1999). Briefly, 1 g of plasma was added to 0.2 g of an internal standard containing AA labeled with stable isotopes, and then the samples were frozen at –80°C. The internal standard solution was prepared with labeled AA diluted in water with the following concentrations (µM): DL-His-
-15N (180), L-Ile-15N (708), L-Leu-1-13C (864), DL-Lys-2-15N-2HCl (486), DL-Met-1-13C (86), L-Phe-1-13C (247), L-Thr-15N (375), L-Val-15N (835), L-Ala-1-13C (1,060), L-Glu-1-13C (273), L-Gln-1-13C (949), L-Gly-1-13C (1,131), L-Ser-1-13C (491), and L-Tyr-15N (245). Labeled AA (95 to 99 atom %) were supplied by CDN isotopes (Montreal, Québec, Canada) for His, Leu, Lys, Met, and Phe and Cambridge Isotope Lab (Andover, MA) for others.
Calculations
From the single bolus dose of NaH13CO3, RaCO2 was calculated as follows (Elia et al., 1992; Junghans et al., 2007):
![]() | [1] |
where the RaCO2 excreted in blood is in moles during 6 h, the 13C dose administered is D (mol), and the area under the blood CO2 13C enrichment-time curve is A(13C). The 6-h period corresponds to the time when blood CO2 isotopic enrichment returned to baseline. The 6-h value was scaled up to 1 d by multiplying by 4 considering the animals were in nutritional steady state induced by frequent meal feeding.
Determination of the RaGluc, determined from the constant infusion of the D-[U-13C6]glucose was calculated as follows (Tserng and Kalhan, 1983):
![]() | [2] |
where RaGluc (mol/h) is the rate of appearance of glucose, IR (mol/h) is the infusion rate of D-[U-13C6]glucose, and Eglucose (MPE) is the steady-state isotopic enrichment of plasma [U-13C6]glucose (Figure 2
). The hourly value was scaled up to 1 d.
Glucose oxidation was calculated as follows (Kien, 1989):
![]() | [3] |
where GOx (mol/h) is the rate of glucose oxidation, ECO2 (APE) is the steady-state 13C enrichment of CO2 from oxidized glucose in blood, Eglucose (MPE) is the steady-state 13C enrichment of [U-13C6]glucose in plasma, and RaCO2 is the rate of CO2 appearance as calculated in equation [1]. Steady-state isotopic enrichments of glucose and CO2 sampled from 70 to 220 min after the onset of the labeled glucose infusion were averaged and used in this calculation (Figure 2
).
Plasma flow across the PDV was calculated from downstream dilution of pAH infusion (Katz and Bergman, 1969). If, within 1 sampling day, the CV of the measured plasma flow for a cow was greater than 25% due to only 1 sample, then this value was removed: this only occurred for 1 sampling time in 1 cow (period 1). We assumed that this high CV was due to an improper mixing of the pAH infused, and therefore, the concentration data for this sampling time were not discarded. Net portal fluxes of metabolites and hormones were calculated for each cow and feeding period as the product of the average venous-arterial concentration difference with the average plasma flow. A negative flux indicates utilization or removal, whereas a positive flux indicates net production or release of the nutrient across tissue bed.
Statistical Analyses
Data for nutrient intake, milk parameters, and measurements in blood are presented as LSM ± pooled standard error of the means. Due to the loss of 1 cow, the originally planned Latin square could not be conducted as expected. Because cows were on a SD during the recovery period, the first experimental period tested this diet on the 3 remaining cows, and the FB diet was tested in the second period, acknowledging that treatment and period effects would then be confounded, but after 100 DIM, when changes in feed intake and milk production with time are small, and with 21-d experimental periods, a time effect was unlikely to occur, as also suggested in the literature (Huntington, 1999). Also, during the second period, the portal catheter of 1 cow was not patent, so flux data for period 2 only include 2 cows. Main effects of treatments on plasma concentrations of metabolites and hormones were assessed using the repeated methods of the MIXED procedure (SAS, 1995). Diet and time of blood sampling were used as fixed effects and individual cows as random effects. Differences were defined by Tukey t test with P < 0.1 for a trend and P < 0.05 for significant difference. Net portal flux data, averaged per cow x period and glucose kinetics were tested using the MIXED procedure (SAS, 1995). Diet was used as fixed effect and individual cows as random effect. Differences were localized by LSD t test with P < 0.1 for a trend and P < 0.05 for a significant difference.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
The rate of glucose appearance (the sum of glucose absorption, gluconeogenesis, and glucose turnover from the glycogen pool) was not affected by diets and was in the range of values previously reported (Bauman et al., 1988; Knowlton et al., 1998, Lemosquet et al., 2004). In cows abomasally infused with LCFA, glucose postliver supply tended to decrease, but LCFA also reduced DMI to a greater extent than in the current study (Benson et al., 2002). Lactose yield relative to the RaGluc averaged 57 vs. 62% for SD vs. FD, respectively. This suggests that with FD, a greater proportion of available glucose was used for lactose synthesis compared with SD-fed cows. Indeed, when LCFA are supplemented, they are preferentially taken up by the mammary gland and directly incorporated into milk fat: a decrease in de novo synthesis of palmitic acid and shorter fatty acids from acetate contributes to reduce the oxidative use of glucose required for producing NADPH and therefore increases glucose partitioning toward lactose production (Palmquist and Jenkins, 1980; Emery and Herdt, 1991; Grummer and Carroll, 1991). In addition, the lower milk fat content in FD-fed cows allowed for even greater use of glucose for lactose synthesis. Because milk yield strongly depends on mammary availability of glucose and on lactose production (Rigout et al., 2002; Brockman, 2005), the mammary metabolic changes outlined above may explain the slightly enhanced milk yield observed with FD feeding. However, a reduced whole body GluOx was not observed with the FD feeding, and it represented on average only 13% of RaGluc for both dietary treatments. Whole body measurements might not be sensitive enough for the fine mammary adjustments likely occurring in this study. Furthermore, the oxidation rate measured through the recovery of glucose carbons in CO2 is a minimum estimate, because it accounts only for the carbons of glucose that are recovered in CO2, and not for all the other carbons of glucose that have been incorporated into intermediate products.
Arterial Concentrations and Net Portal Flux
Portal plasma flow increased in FD-fed cows as observed in response to abomasal infusion of LCFA in dairy cows (Benson et al., 2002). Reasons for this finding are presently unknown, particularly because ME intake that affects portal blood flow in cattle (Reynolds, 1995) was not different between treatments.
Feeding the FD reduced plasma glucose concentrations, as reported previously in most (Benson et al., 2002; Drackley et al., 2003; Voigt et al., 2005) but not all studies (Smith et al., 1978; Blum et al., 1999) with LCFA supplementation. In our study, the decrease in plasma glucose concentration was not associated with decreased postabsorptive availability of glucose, because RaGluc was not affected by the diet. Therefore, the reduced glucose concentration was likely due to an increased utilization of glucose. First, the increased lactose yield with the FD reflects increased glucose use, but this was only equivalent to 21 mmol/h (i.e., approximately 4% of the RaGluc). With both diets, there was no net portal absorption of glucose but rather an uptake by the PDV, as often reported in dairy cows (Reynolds, 1995; Benson et al., 2002). Although not significant, the net PDV uptake of glucose increased with FD feeding, and this increment represented up to 14% of the RaGluc. Because an infusion of LCFA does not alter net glucose portal absorption (Benson et al., 2002), the smaller PDV glucose uptake in cows fed SD may be due to utilization by the small intestine of glucose available from starch intestinal digestion, thereby decreasing PDV utilization of arterial glucose and increasing the net portal absorption of glucose.
Plasma lactate concentrations increased with the FD, with no effect of the diets on its net portal absorption. Similarly, Benson et al. (2002) did not observe any effect of LCFA infusion on lactate net portal absorption, but they observed an increased hepatic uptake. Elevated plasma concentrations of triglycerides in FD-fed cows were expected (Smith et al., 1978; Palmquist and Jenkins, 1980; Emery and Herdt, 1991; van Knegsel et al., 2005). In addition, plasma NEFA increased in FD-fed cows when compared with SD-fed cows, in line with previous findings (Smith et al., 1978; Benson et al., 2002; Voigt et al., 2005). Obviously, fatty acids are hydrolyzed from triglycerides by lipoprotein lipases, and those escaping uptake by tissue beds contribute to elevated plasma NEFA concentrations (Grummer and Carroll, 1991; Chilliard, 1993). In addition, hepatic lipolytic activities are potentially enhanced during fat feeding (Chilliard, 1993). Reduced insulin plasma concentrations, as discussed later, or impaired insulin action due to high fat intake may also support NEFA release from adipose tissues in dairy cows (Chilliard, 1993). However, fat feeding did not affect insulin action as indicated by glucose clamp studies in dairy cows (Blum et al., 1999). Higher plasma NEFA concentrations may lead to elevated fatty acid oxidation, preferentially in the muscle and liver, which seems to have an impact on feed intake (Allen et al., 2005) and therefore might partly explain lower DMI in FD-fed cows in the current study.
Free AA concentrations in plasma and net portal absorption were not affected by treatments, with the exception of Ile and Leu arterial concentrations, which increased, whereas Gln, Glu, and Ser concentrations decreased with FD. Concentrations of the branched-chained AA are more closely related with protein supply, because they are barely removed by the liver (Raggio, 2006), and altogether, this suggests that feeding protected soy in FD increased utilizable protein supply, as discussed above. In addition, there was a tendency for increased insulin concentrations in cows fed SD, with the difference being significant (P < 0.05) at the portal level (portal insulin plasma concentrations LSM for SD vs. FD ± pooled SEM: 0.95 vs. 0.63 ± 0.07 mmol/h). Increased insulin concentrations are usually linked with decreased branched-chain AA concentration (Mackle et al., 2000). Lower plasma insulin concentrations were observed in some previous studies feeding RPF to dairy cows (van Knegsel et al., 2005; Voigt et al., 2005) but not in all (Blum et al., 1999). Benson and Reynolds (2001) reported a trend for reduced insulin concentrations and a reduced portal-arterial difference of insulin concentrations with infusion of LCFA to dairy cows, but net PDV flux for insulin did not change. Because arterial glucose concentration was reduced due to fat feeding, this might have lowered pancreatic insulin secretion. On the other hand, plasma glucagon increased with fat feeding, resulting in a significantly greater glucagon-to-insulin ratio when fed FD compared with SD. Benson and Reynolds (2001) also observed a trend for higher arterial glucagon concentrations with LCFA infusion in the abomasum, with a numerical increment in net PDV flux of glucagon, as observed in the present study. Glucagon stimulates endogenous glucose production (gluconeogenesis and glycogenolysis) in ruminants, and glucagon administration improves the glucose status in lactating dairy cows (Drackley et al., 2001; Bobe et al., 2003). However, our results indicated no changes in RaGluc, and even lower plasma glucose concentrations were observed in spite of elevated glucagon-to-insulin ratios. In addition, Benson et al. (2002) have found a trend for reduced hepatic glucose release with LCFA infusion, although arterial pancreatic glucagon concentrations were elevated (Benson and Reynolds, 2001). Therefore, it remains to be resolved whether and how the increased glucagon-to-insulin ratio affects endogenous glucose production in FD-fed cows.
In conclusion, substituting starch by RPF in a dairy ration increased milk and lactose yields but decreased plasma concentrations of glucose. Our study clearly showed that whole body rate of glucose appearance was not affected by RPF feeding. This suggests a more efficient use of available glucose for milk lactose synthesis when feeding RPF. Whether changes in glucose availability are related to endocrine regulation of nutrient partitioning during lactation, with the large increment of the ratio of glucagon to insulin observed in this study in cows fed the FD, needs further investigations.
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
Received for publication July 12, 2007. Accepted for publication September 27, 2007.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
H. M. Hammon, G. Sturmer, F. Schneider, A. Tuchscherer, H. Blum, T. Engelhard, A. Genzel, R. Staufenbiel, and W. Kanitz Performance and metabolic and endocrine changes with emphasis on glucose metabolism in high-yielding dairy cows with high and low fat content in liver after calving J Dairy Sci, April 1, 2009; 92(4): 1554 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Preynat, H. Lapierre, M. C. Thivierge, M. F. Palin, J. J. Matte, A. Desrochers, and C. L. Girard Effects of supplements of folic acid, vitamin B12, and rumen-protected methionine on whole body metabolism of methionine and glucose in lactating dairy cows J Dairy Sci, February 1, 2009; 92(2): 677 - 689. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |